PhRMA president and CEO Stephen J. Ubl joined Fox Business’ Maria Bartiromo on “Mornings with Maria” today to discuss bold steps the biopharmaceutical industry has taken in the last few months as part of its commitment to advance a multifaceted solution to address the opioid crisis. Most recently, PhRMA announced its support for policies limiting the supply of opioids to seven days for acute pain treatment.
PhRMA has also been working closely with the President’s Commission on Combating Drug Addiction and the Opioid Crisis, the National Institutes of Health (NIH) and the Food and Drug Administration to develop a public-private partnership that will accelerate the development of non-opioid, non-addictive pain medicines and medication-assisted treatments for long-term addiction recovery. The public-private partnership would allow increased information sharing and collaboration between government and industry to speed the drug development process.
Holly Campbell Holly Campbell is a deputy vice president of public affairs at PhRMA focusing on the cost and value of medicines. Prior to joining PhRMA, Holly worked for large and small public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups.